Drug firm Alembic Pharmaceuticals on Thursday reported a 81 per cent rise in its consolidated net profit at Rs 224.93 crore for the fourth quarter ended March 31, 2020 mainly on account of robust sales in international markets.
The company had posted a net profit of Rs 124 crore for the corresponding period of the previous fiscal,Alembic Pharmaceuticals said in a regulatory filing.
Consolidated revenue from operations of the company rose to Rs 1,206.83 crore for the quarter under consideration as against Rs926.95 crore for the same period a year ago.
For the fiscal year ended March 31, 2020, the consolidated net profit of the company rose to Rs829.12 crore as against Rs584.37 crore for the previous fiscal year.
Consolidated revenue from operations for the fiscal year ended March this year rose to Rs 4,605.75 crore as against Rs 3,934.68 crore for the year ago period.
"It was a remarkable year for the company where we recorded our highest revenue and profit ever. This was led by strong growth in the US generics business. During the fourth quarter we saw our India and rest of world (ROW) business also getting back to a robust growth," Alembic Pharmaceuticals MD Pranav Aminsaid.
Shares of Alembic Pharmaceuticals closed at Rs698.55per scrip on BSE, up 9.56 per cent from its previous close.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app